Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) |
---|---|
Disease/Condition | Lung Cancer,Solid Tumor,Lung Diseases,Carcinoma,Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Haiying Cheng, MD |
Contact Name | Remy Lambert |
Contact Email | rlambert@montefiore.org |
Protocol Number | 2016-7018 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Early-stage NSCLC |
Adult, Pediatric, Both | Adult |